LACTO-N-BIOSE CONVERTING FUCOSYLTRANSFERASES

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20240327888A1
SERIAL NO

18579664

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is in the technical field of synthetic biology and metabolic engineering. More particularly, the present invention is in the technical field of metabolically engineered cells and use of said cells in a cultivation, preferably a fermentation. The present invention describes a cell and a method for production of a compound. The cell expresses an alpha-1,2-fucosyltransferase that has galactoside alpha-1,2-fucosyltransferase activity on the galactose residue of Gal-b1,3-GlcNAc (LNB, lacto-N-biose). Furthermore, the present invention provides for purification of said compound from the cultivation.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INBIOSE N VGHENT

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Aesaert, Sofie Zwijnaarde, BE 12 1
Beauprez, Joeri Zwijnaarde, BE 46 27
Peters, Gert Zwijnaarde, BE 15 1
Vandewalle, Kristof Zwijnaarde, BE 20 7
Vercauteren, Annelies Zwijnaarde, BE 22 1

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation